Immunoassay Analyzers Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Immunoassay Analyzers Market By Product (Chemiluminescence Immunoassay Analyzers, Radioimmunoassay Analyzers, Immunofluorescence Analyzers, ELISA Analyzers, Consumables), By Application (Oncology, Therapeutic Drug Monitoring, Cardiology, Autoimmune Disease, Infectious Disease Testing),  Based on end user (Biotechnological Firms, Research Organizations, Diagnostic Centers, Others)  and  Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Immunoassay Analyzers Market size was valued at USD 39.5 billion in 2021, at a CAGR of 5.2% during the forecast period 2022-28. Immunoassay analyzers are the instruments which are used in clinical settings, hospitals or maybe the research organizations to run the biochemical tests to detect the concentration of samples. The market for immuno analyzers is growing due to the increased prevalence of disease outbreaks such as Zika and the rising incidence of chronic diseases such as hepatitis. Furthermore, advances in laboratory automation and integration, as well as preventative healthcare, are creating prospects for the global immunoassay analyzers market growth. Immunoassay analyzers are extensively used in clinical laboratories and hospitals to perform biochemical tests aimed at detecting and measuring the quantity of chemicals in samples. Small scale laboratories have a long time to adjust to changes in instrumentation due to factors such as system revaluation, staff training, procedure standardisation, and lengthy purchase processes. Manufacturers, on the other hand, are seeking to make more affordable analyzer systems or provide replacement benefits to create revenue. Companies operating in global immuno analyzers market are focusing on the new product developments and launches to strengthen their position.

Key Developments:

In September 2017 Siemens got CE Mark and launched its Atellica Solution flexible, scalable, automation-ready immunoassay and chemistry analyzer

In March 2016, Diasorin S.p.A. has entered into the agreement to acquire Quest’s Focus Diagnostics, Inc. molecular diagnostic and immunodiagnostic products business.

In September 2014, Sysmex Corp. has launched Automated, compact Immunoassay System HISCL 800 for immunochemistry testing for increasingly diverse needs. Furthermore, companies also adapting the strategies such as acquisitions and collaboration to increase their product portfolio and market share.

Immunoassay Analyzers Market

MARKET SUMMARY
-
5.2%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 5.2%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Immunoassay Analyzers Market

  • The report on global immuno analyzers market gives historical, current, and future market sizes (US$ Bn) on the basis of product type, application, end-user and geography.
  •  immuno analyzers market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Abbott
  • bioMérieux SA
  • Biokit S.A.
  • DiaSorin S.p.A.
  • Hoffmann-La Roche Ltd.
Immunoassay Analyzers Market Dynamics

Global immune analyzers market is primarily driven by adaptation of the automated instruments in the research and other commercial organizations, especially in developed countries. In addition, growing prevalence of the chronic conditions, infectious diseases and R&D investments in biotechnological companies around the world. Furthermore, advancements in the immune analyzers such as advent of portable immune assay analyzers and new product launches are expected to boost the market growth over the forecast period. However, high cost of devices and lack of skilled professionals are expected to hamper the market growth over the forecast period.


North-America Got Significant Share

Immunoassay Analyzers Market

Geographically, global immuno analyzers market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America immune analyzers market is expected to grow at notable rates owing to the technological advancements and presence of key market players in the region. In addition, recent product launches and collaboration of various organizations in advancing the biotechnology to diagnose and treat diseases projected to boost the market share in the region. For Instance, Abbot Laboratories has launched Automated Immunoassay instrument Architect i1000SR. Europe immune analyzers market projected to have significant market share due to the presence of key market players and adaptation of automated instruments and increased fundings in biotechnological firms. Asia Pacific region projected to have lucrative market growth opportunity owing to the increase in the prevalence of chronic and infectious diseases. The countries such as India and China expected to contribute significant share in regional market owing to increase in the R&D investment by the companies and adaptation of automated instruments in many organizations

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2017 to 2021) and forecast (2022 to 2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Immunoassay Analyzers Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

  • Abbott
  • BD
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Biokit S.A.
  • DiaSorin S.p.A.
  • Hoffmann-La Roche Ltd.
  • Immunodiagnostic Systems
  • Luminex Corporation
  • Merck KGaA
  • Nova Century Scientific, Inc.
  • Olympus Corporation
  • Ortho Clinical Diagnostics
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Siemens
  • Tecan Trading AG
  • The Binding Site Group Ltd.
  • Thermo Fisher Scientific, Inc.

Description

Immunoassay Analyzers Market size was valued at USD 39.5 billion in 2021, at a CAGR of 5.2% during the forecast period 2022-28. Immunoassay analyzers are the instruments which are used in clinical settings, hospitals or maybe the research organizations to run the biochemical tests to detect the concentration of samples. The market for immuno analyzers is growing due to the increased prevalence of disease outbreaks such as Zika and the rising incidence of chronic diseases such as hepatitis. Furthermore, advances in laboratory automation and integration, as well as preventative healthcare, are creating prospects for the global immunoassay analyzers market growth. Immunoassay analyzers are extensively used in clinical laboratories and hospitals to perform biochemical tests aimed at detecting and measuring the quantity of chemicals in samples. Small scale laboratories have a long time to adjust to changes in instrumentation due to factors such as system revaluation, staff training, procedure standardisation, and lengthy purchase processes. Manufacturers, on the other hand, are seeking to make more affordable analyzer systems or provide replacement benefits to create revenue. Companies operating in global immuno analyzers market are focusing on the new product developments and launches to strengthen their position.

Key Developments:

In September 2017 Siemens got CE Mark and launched its Atellica Solution flexible, scalable, automation-ready immunoassay and chemistry analyzer

In March 2016, Diasorin S.p.A. has entered into the agreement to acquire Quest’s Focus Diagnostics, Inc. molecular diagnostic and immunodiagnostic products business.

In September 2014, Sysmex Corp. has launched Automated, compact Immunoassay System HISCL 800 for immunochemistry testing for increasingly diverse needs. Furthermore, companies also adapting the strategies such as acquisitions and collaboration to increase their product portfolio and market share.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX